New research from Rutgers Health reveals an unexpected mechanism through which antibiotics may inadvertently promote bacterial survival and accelerate resistance development. The study, published in Nature Communications, demonstrates how ciprofloxacin, a commonly prescribed antibiotic for urinary tract infections, creates metabolic conditions that help bacteria endure treatment.
Energy Crisis Triggers Survival Response
Researchers focused on how ciprofloxacin affects bacterial energy systems, specifically adenosine triphosphate (ATP), which serves as cellular fuel. When ATP levels decline dramatically, bacteria experience what scientists term “bioenergetic stress.” The research team, led by medical student Barry Li and assistant professor Jason Yang, engineered E. coli strains with genetic modifications that continuously depleted ATP and its related molecule nicotinamide adenine dinucleotide (NADH).
Testing these modified bacteria against ciprofloxacin produced surprising results. Rather than weakening under the combined pressure of energy depletion and antibiotic treatment, the bacteria responded by increasing their metabolic activity. Cellular respiration accelerated, generating elevated levels of reactive oxygen molecules that can damage DNA.
Dual Survival Advantages
This metabolic acceleration created two significant survival benefits for the bacteria. First, substantially more bacterial cells survived lethal antibiotic doses. Time-kill experiments showed that energy-stressed bacteria had ten times higher survival rates compared to unstressed control groups. These surviving bacteria, known as persister cells, remain dormant during treatment but can reactivate once antibiotics are eliminated, potentially triggering recurring infections.
The enhanced survival contradicts previous assumptions that slower bacterial metabolism contributes to persister cell formation. Instead, the research indicates that bacteria accelerate their metabolism to replenish energy reserves, activating stress response systems that provide protection against antibiotic effects.
Accelerated Resistance Evolution
The second concerning outcome involved faster development of genetic resistance. The research team exposed E. coli populations to progressively higher ciprofloxacin concentrations, finding that energy-stressed bacteria achieved resistance thresholds four treatment cycles earlier than normal bacteria. DNA analysis revealed that oxidative damage and subsequent error-prone cellular repair mechanisms drove these rapid mutations.
Broader Implications
Preliminary investigations suggest this energy-drain phenomenon extends beyond ciprofloxacin to other antibiotics including gentamicin and ampicillin. The metabolic stress response may affect diverse bacterial pathogens, including Mycobacterium tuberculosis, which demonstrates particular sensitivity to ATP disruption.
Given that antibiotic resistance contributes to approximately 1.27 million annual deaths globally, these findings suggest important considerations for future treatment strategies. The research team proposes several potential approaches, including screening new antibiotics for energy-disruption effects, combining existing drugs with compounds that counteract stress pathways, and reconsidering high-dose treatment protocols that may inadvertently trigger protective bacterial responses.
Current plans include testing compounds that reduce bioenergetic stress to potentially restore antibiotic effectiveness.
